Report - Vinflunine (HALAVEN): + 3 mois (SG) Evérolimus (AFINITOR)+ EXEMESTANE + 6 mois (SSR) Ciblage HER2: - Trastuzumab (HERCEPTIN) - Pertuzumab (PERGETTA):

Please pass captcha verification before submit form